Advertisement
Singapore markets closed
  • Straits Times Index

    3,292.69
    +10.64 (+0.32%)
     
  • Nikkei

    38,274.05
    -131.61 (-0.34%)
     
  • Hang Seng

    17,763.03
    +16.12 (+0.09%)
     
  • FTSE 100

    8,155.15
    +11.02 (+0.14%)
     
  • Bitcoin USD

    57,247.02
    -4,418.23 (-7.16%)
     
  • CMC Crypto 200

    1,234.27
    -104.79 (-7.83%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • Dow

    37,815.92
    -570.17 (-1.49%)
     
  • Nasdaq

    15,657.82
    -325.26 (-2.04%)
     
  • Gold

    2,298.70
    -4.20 (-0.18%)
     
  • Crude Oil

    80.52
    -1.41 (-1.72%)
     
  • 10-Yr Bond

    4.6860
    +0.0720 (+1.56%)
     
  • FTSE Bursa Malaysia

    1,575.97
    -6.69 (-0.42%)
     
  • Jakarta Composite Index

    7,234.20
    +78.41 (+1.10%)
     
  • PSE Index

    6,700.49
    -69.15 (-1.02%)
     

New Strong Buy Stocks for April 17th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Byrna Technologies Inc. BYRN:  This non-lethal defense technology companyhas seen the Zacks Consensus Estimate for its current year earnings increasing 157.1% over the last 60 days.

Byrna Technologies Inc. Price and Consensus

Byrna Technologies Inc. Price and Consensus
Byrna Technologies Inc. Price and Consensus

Byrna Technologies Inc. price-consensus-chart | Byrna Technologies Inc. Quote

Y-mAbs Therapeutics, Inc. YMAB: This commercial-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 42.7% over the last 60 days.

Y-mAbs Therapeutics, Inc. Price and Consensus

Y-mAbs Therapeutics, Inc. Price and Consensus
Y-mAbs Therapeutics, Inc. Price and Consensus

Y-mAbs Therapeutics, Inc. price-consensus-chart | Y-mAbs Therapeutics, Inc. Quote

ADVERTISEMENT

Sandstorm Gold Ltd. SAND: This gold royalty company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.

Sandstorm Gold Ltd Price and Consensus

Sandstorm Gold Ltd Price and Consensus
Sandstorm Gold Ltd Price and Consensus

Sandstorm Gold Ltd price-consensus-chart | Sandstorm Gold Ltd Quote

Corcept Therapeutics Incorporated CORT: This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 27.8% over the last 60 days.

Corcept Therapeutics Incorporated Price and Consensus

Corcept Therapeutics Incorporated Price and Consensus
Corcept Therapeutics Incorporated Price and Consensus

Corcept Therapeutics Incorporated price-consensus-chart | Corcept Therapeutics Incorporated Quote

Enveric Biosciences, Inc. ENVB: This biotechnology company has seen the Zacks Consensus Estimate for its next year earnings increasing 25.6% over the last 60 days.

Enveric Biosciences, Inc. Price and Consensus

Enveric Biosciences, Inc. Price and Consensus
Enveric Biosciences, Inc. Price and Consensus

Enveric Biosciences, Inc. price-consensus-chart | Enveric Biosciences, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Corcept Therapeutics Incorporated (CORT) : Free Stock Analysis Report

Sandstorm Gold Ltd (SAND) : Free Stock Analysis Report

Y-mAbs Therapeutics, Inc. (YMAB) : Free Stock Analysis Report

Byrna Technologies Inc. (BYRN) : Free Stock Analysis Report

Enveric Biosciences, Inc. (ENVB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research